U.S. Pharmaceutical Distribution Giant Director Makes Bold Purchase of $1.5 Million in Company Stock

On June 18, D. Mark Durcan, a member of Cencora’s board of directors, acquired approximately $1.1 million of the company’s shares in open‐market transactions—about KRW 1.5 billion—raising the value of his direct stake to roughly $8.6 million (around KRW 12 billion).

On June 22, insider Lauren M. Tyler made additional purchases totaling several hundred thousand dollars (approximately KRW 200 million), increasing her direct holding to about $1.18 million (around KRW 1.6 billion).

The company also announced that Chief Human Resources Officer Silvana Battaglia, who had served for seven years, retired on June 15. Effective July 13, Samantha Hammock—formerly head of HR at Verizon and American Express—will assume the role of CHRO as part of a global HR reorganization.

On June 29, Cencora appointed Eva C. Boratto, previously CFO of CVS and Bath & Body Works, as its new Executive Vice President and Chief Financial Officer. At the same time, the company reaffirmed its fiscal 2026 and medium-term adjusted EPS growth guidance. (Source: investor.cencora.com)

Headquartered in Conshohocken, Pennsylvania, Cencora is a global pharmaceutical wholesale and distribution company. Formerly known as AmerisourceBergen, it trades on the New York Stock Exchange under the ticker COR. With annual revenues exceeding $300 billion, Cencora ranks among the Fortune 500’s top healthcare distributors. (Source: en.wikipedia.org)